Associazione Nazionale Medici Cardiologi Ospedalieri

CONGRESS ABSTRACT

CONGRESS ABSTRACT

Categorie
THE ROLE OF BIOELECTRICAL PHASE ANGLE IN PATIENTS WITH HEART FAILURE
Anno:
2023
The most challenging feature of heart failure (HF) still remains the evaluation of congestion. Residual congestion at discharge and the difficulties in perfectly dosing therapies in order to balance the hydration status of the patient are the most worrisome issues when dealing with HF. The use of bioimpedance vector…
Does cardiac amyloidosis ever hide a severe aortic stenosis A case report
Anno:
2023
Case presentation: A 89-year-old man, with an history of paroxysmal atrial fibrillation and chronic renal disease, was admitted to our ER for acute decompensated heart failure. He reported dyspnea on minimal exertion and worsening peripheral edema. He had a history of heart failure and a severe aortic stenosis first diagnosed in 2020…
SIDE EFFECTS OF SGLT-2 INHIBITORS IN PATIENTS WITH HEART FAILURE: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
Anno:
2023
Background: sodium-glucose cotransoporter-2 inhibitors (SGLT-2Is) improve prognosis in heart failure patients both with reduced (HFrEF) and preserved ejection fraction (HFpEF). However, these drugs can have some side effects. Purpose: estimate the relative risk of side effects in HF patients treated with SGLT-2Is irrespectively from left ventricular EF and setting…
Dapagliflozin use in HFrEF patients: a single centre comparison between real-life and DAPA-HF data
Anno:
2023
Background: Practice guidelines recommend Sodium-glucose co-transporter-2 inhibitors (SGLT2-i) for patients with heart failure with reduced ejection fraction (HFrEF). Our study aimed to describe our population of patients with indications for Dapagliflozin, to compare it with the DAPA-HF trial population and assess the possible prognostic evolution. Methods: We retrospectively analysed…
Baseline albuminuria and heart failure during hospitalization with ACS and long-term death risk. Results From 24 Years of Follow-up of The ABC Study on Heart Disease.
Anno:
2023
Background: Both albuminuria and heart failure are known predictors of poor outcomes in patients with acute coronary syndrome (ACS). Purpose: To assess the combined effect of albuminuria and heart failure on the long-term mortality risk prediction 24 years after ACS. Methods: The present analysis includes 589 patients with ACS…
Incidental diagnosis of massive mobile left ventricle thrombi following COVID-19 infection in a heart failure patient
Anno:
2023
Background: Intracardiac thrombus can be a complication of ischemic heart disease and cardiomyopathies. The advancements in imaging modalities have increased the capacity to diagnose this condition helping to reduce the associated complications (i.e. embolization). Previous reports suggest a possible link between intracardiac thrombosis and COVID-19 infection, especially in patients…
Impact of personal protective masks on cardiorespiratory variables in healthy subjects and patients with heart failure: an interim analysis
Anno:
2023
Background: protective masks are a powerful mean to contain COVID-19. However, a general feeling that masks alter the normal dynamics of breathing may reduce its application. Patients with heart failure (HF) experience dyspnea even during daily life activities (ADLs). Aim of the study is to evaluate cardiorespiratory parameters during ADLs,…
THE IMPORTANCE OF CORRELATION BETWEEN HEART FAILURE AND THYROID: a case report
Anno:
2023
A 39-year-old African man was admitted to our department within a four days symptoms of short of breath, cough, tachycardia and lower limb edema. He also complained headache for about a month. He denied fever, chest pain and loss of consciousness. Clinical and family history were unremarkable.  Blood tests showed…
A HEART OF STONE: A CASE OF APOLIPOPROTEIN A-I CARDIAC AMYLOIDOSIS TREATED WITH HEART TRANSPLANT
Anno:
2023
A 56-year-old woman was referred to our Unit for advanced heart failure refractory to pharmacological therapy with poor functional status (NYHA class IV, INTERMACS profile 4-5). She had a history of restrictive and hypokinetic cardiomyopathy secondary to autosomal dominant hereditary Apolipoprotein A-I (APOA1) amylodosis caused by Leu75Pro mutation, detected both in…
TEAMWORK IS SUCCESSFUL (1): FAVOUREABLE RE-CHALLENGE OF DOUBLE ANTI-HER2 TREATMENT IN SEVERE MYOCARDIAL DYSFUNCTION IN PATIENT WITH ADVANCED BREAST CANCER AND OCCULT TYPE II DIABETES
Anno:
2023
INTRODUCTION Cardiovascular diseases (CVD) and Cancer (C), the most important causes of mortality worldwide. share many risk factors and common pathophysiological processes such as chronic inflammation and unfavorable cardio-metabolic profile. Progress in oncological treatments improved the survival of oncological patients (Pt) but have increased the likelihood of short- and…